NCT03424408View on ClinicalTrials.gov

Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

September 3, 2019

Study Completion Date

September 3, 2019

Conditions
Aspirin
Interventions
DRUG

Aspirin 81 mg

Healthy volunteers will receive 5 days of aspirin 81 mg daily. Following cessation of aspirin, daily blood samples will be collected for serum thromboxane B2 measurement

Trial Locations (1)

L8L 2X2

Thrombosis and Atherosclerosis Research Institute. Hamilton General Site, Hamilton

All Listed Sponsors
lead

Hamilton Health Sciences Corporation

OTHER

NCT03424408 - Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin | Biotech Hunter | Biotech Hunter